Oxford Genetics and Twist Bioscience have signed a new licensing agreement for the SnapFast technology platform.
Sign agreement
Under the terms of the agreement, Oxford Genetics will supply Twist Bioscience with its technology platform to provide a range of application-specific expression vectors, which can then be used to clone synthesized DNA for Twist Bioscience’s customers.
“This license agreement with Twist Bioscience serves as further recognition of our approach to developing the best optimised expression vectors,” stated Dr Ryan Cawood, CEO of Oxford Genetics. “By utilising our SnapFast platform, Twist Bioscience is giving its customers access to the latest vector designs for the most demanding applications and providing them with better value, a streamlined workflow and maximum flexibility in order to utilise their custom DNA constructs to their best effect.”
“By complementing our ability to provide high throughput synthetic genes with a wide range of customized vectors from Oxford Genetics, we accelerate our customer’s workflow, allowing them to solve more complex problems while saving both time and resources,” added Emily M. Leproust, PhD, CEO of Twist Bioscience. “Importantly, it enables us to reach the large group of customers who order smaller quantities of genes in standard vectors. We remain committed to optimizing our product line to enable our customers to succeed more quickly.”